Data / Form D filings / CELLECTAR, Inc.
CELLECTAR, Inc.: Form D filing
CELLECTAR, Inc., a pharmaceuticals company in Madison, WI, filed a Form D with the SEC in 2010. The latest, on February 8, 2010, reports $2.7 million sold of a $2.7 million offering to 9 investors.
Find out what CELLECTAR, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3301 AGRICULTURE DRIVE, Madison, WI, 53716
- Phone
- (608) 441-8120
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506, Securities Act section 4(6)
- SEC identifier (CIK)
- 1212587
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 8, 2010 | New notice | $2,720,985 | $2,720,985 | $0 | 9 | Jan 25, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles J. Harwood | Director | |
| Thomas J. Mackie | Director | |
| Bruce J. Nevaiser | Director | |
| William Clarke | Executive Officer, Director | |
| Terry J. Sivesind | Director | |
| Jamey J. Weichert | Executive Officer, Director | |
| Neal J. Sandy | Executive Officer |
Every Form D from the week of Feb 8, 2010 · All recent filings in Wisconsin · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CELLECTAR, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.